Latest News- Cell Therapy Market: Autologous is expected to lead the Type segment during 2024-2028

The Cell Therapy Market is being driven by Limitations in traditional organ transplantations fueling demand for cell therapies

The Cell Therapy Market is expected to grow at a CAGR of 73.89% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 84584.7 million. In the biotechnology sector, numerous companies, including both small and large entities, are actively engaged in the development of various cell types, such as progenitor cells, adult and embryonic stem cells, and induced pluripotent stem cells (iPS cells). These advanced cell types have demonstrated significant therapeutic potential in the treatment of chronic conditions, including heart failure, cancer, and diabetes. While the market currently offers a range of cell therapy products for wound and dermal grafts, the availability of such treatments for cancer remains relatively limited. In a groundbreaking development, the Food and Drug Administration (FDA) approved PROVENGE in 2010, marking the first cell therapy product for cancer treatment. Dendreon, the manufacturer of PROVENGE, utilizes autologous cells derived from patients, making it a prime example of personalized medicine. Notable industry players, such as Novartis and Opexa, are also progressing with the development of autologous cell therapy-based products. 

Get more information on Cell Therapy Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Autologous
  • Allogenic
• Application
  • Malignancies
  • Musculoskeletal
  • Cardiovascular
  • Others
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Limitations in traditional organ transplantations fueling demand for cell therapies
• Increasing funding in cell-based research
• Proven effectiveness of CAR T-cell therapy

However, the market also witnesses some limitations, which are as follows:

• High cost and failure rate in clinical trials
• Strict regulatory approval for product launch of cell therapy products
• Ethical concerns related to stem cell research

Benefits of Buying Global Cell Therapy Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Cell Therapy Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Cell Therapy Market is experiencing innovation through the development of novel products, with a focus on understanding disease mechanisms and halting disease progression. Treatment responses, global population growth, climate change, and virus outbreaks drive market demand. Cell biology research explores various cell types and cell banking facilities. Clinical trials, led by companies like Achilles Therapeutics, are underway for chronic conditions, with funding from initiatives like Horizon Europe. Regenerative medicine and clinical studies advance allogeneic therapies.

Market Research Overview

The Cell Therapy Market, a segment of the larger global pharmaceuticals industry, encompasses organizations involved in the research and development (R&D) or production of cell therapies, including stem cell therapies and gene therapies. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the expansion of the pharmaceuticals market include the increasing global population, particularly the aging demographic, with the US and Europe projected to have over 25% of their populations aged 60 and above by 2050 and 2030, respectively. Additionally, disease mechanisms, disease progression, treatment responses, novel products, climate change, and virus outbreaks continue to fuel cell biology research and the development of advanced therapies.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/